Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
68.8M
-
Shares change
-
+1.67M
-
Total reported value, excl. options
-
$2.83B
-
Value change
-
+$68.9M
-
Put/Call ratio
-
1.32
-
Number of buys
-
97
-
Number of sells
-
-94
-
Price
-
$41.12
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2020
246 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2020.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.8M shares
of 101M outstanding shares and own 68.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.53M shares), VANGUARD GROUP INC (7.37M shares), PRIMECAP MANAGEMENT CO/CA/ (7.08M shares), FMR LLC (6.6M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.85M shares), JANUS HENDERSON GROUP PLC (3.31M shares), STATE STREET CORP (2.8M shares), JPMORGAN CHASE & CO (1.93M shares), and FARALLON CAPITAL MANAGEMENT LLC (1.85M shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.